Skip to main content
Monday, November 16, 2026Nov 16

Tennessee judge rules pretrial against opioid firm; cites delays, lies

FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. The global business consulting firm McKinsey & Company has agreed to a $573 million settlement over its role in the opioid crisis, according to a person with knowledge of the deal. An announcement is expected Thursday, Feb. 4, 2021. (AP Photo/Toby Talbot, File)
FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. The global business consulting firm McKinsey & Company has agreed to a $573 million settlement over its role in the opioid crisis, according to a person with knowledge of the deal. An announcement is expected Thursday, Feb. 4, 2021. (AP Photo/Toby Talbot, File)

NASHVILLE, Tenn. (AP) – A Tennessee judge has made a rare move to rule against an opioid firm before a civil trial over its role in the epidemic, saying there was a “coordinated strategy” by the company and its attorneys to delay proceedings, deprive plaintiffs of information and interfere with the administration of justice.

In Sullivan County Circuit Court on Tuesday, Chancellor E.G. Moody entered the default judgment against Endo Pharmaceuticals, saying the company willfully withheld records during legal discovery to gain an edge at trial. In the ruling, the judge cited a dozen falsehoods from Endo’s legal team as the case played out.

The ruling finds the opioid manufacturer and another Endo subsidiary liable and sends the case right to a trial over damages.

“Although this is a harsh sanction, justice demands it under the circumstances,” Moody wrote. “Anything less would make a mockery of the attorneys who play by the rules and the legal system.”

The company indicated Wednesday that it plans to appeal the judge’s orders in the case, calling them “procedurally, factually, and legally deficient.”